ARTICLE | Clinical News
Synsorb-Cd: Phase III testing update
December 17, 2001 8:00 AM UTC
Synsorb Biotech Inc. (TSE:SYB; SYBB), Calgary, Alberta Product: Synsorb-Cd Business: Infectious diseases Therapeutic category: Bacterial infection Target: Clostridium difficile toxin Description: Olig...